Meridian Bioscience, Inc. (VIVO) Misses Q4 EPS by 1c; Reaffirms

November 7, 2013 8:38 AM

Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q4 EPS of $0.22, $0.01 worse than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found